Cargando…
MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457438/ https://www.ncbi.nlm.nih.gov/pubmed/34566431 http://dx.doi.org/10.2147/CMAR.S339427 |
| _version_ | 1784571094696460288 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8457438 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84574382021-09-23 MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction] Cancer Manag Res Retraction Dove 2021-09-18 /pmc/articles/PMC8457438/ /pubmed/34566431 http://dx.doi.org/10.2147/CMAR.S339427 Text en © 2021 Dove Medical Press. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Retraction MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction] |
| title | MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction] |
| title_full | MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction] |
| title_fullStr | MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction] |
| title_full_unstemmed | MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction] |
| title_short | MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction] |
| title_sort | microrna-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the wnt/β-catenin pathway [retraction] |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457438/ https://www.ncbi.nlm.nih.gov/pubmed/34566431 http://dx.doi.org/10.2147/CMAR.S339427 |